Filing Details
- Accession Number:
- 0001127602-23-013708
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-28 06:46:20
- Reporting Period:
- 2023-04-27
- Accepted Time:
- 2023-04-28 06:46:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1878313 | Maia Biotechnology Inc. | MAIA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1913199 | Stan Smith | 444 West Lake Street, Suite 1700 Chicago IL 60606 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-04-27 | 133,300 | $2.25 | 686,628 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Footnote |
Footnotes
- These shares were purchased by the reporting person in the issuer's follow-on offering, which closed on April 27, 2023.
- These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.